Could fasting help prostate cancer treatment? small study aims to find out

NCT ID NCT06172283

Recruiting now Symptom relief Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether intermittent fasting (with an optional plant-rich diet) is practical and helpful for 30 men with prostate cancer who are receiving hormone therapy (androgen deprivation therapy). The main goal is to see if patients can stick with the diet, not yet to prove it works. Researchers will also look for early signs of tumor response and any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: intermittent fasting (caloric restriction with optional plant-enriched diet)
What this could lead to: If this approach works, it could point toward a way to improve treatment outcomes and reduce side effects for prostate cancer patients on hormone therapy.
What could go wrong: This is a very small, early pilot study with only 30 participants, focused on feasibility rather than proof of benefit. The diet may be hard to stick with, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

University at Buffalo/Great Lakes Cancer Center
RECRUITING

Buffalo, New York, 14203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.